Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?

• Other Authors: Kuo, Hann-Chorng (Editor)
• Format: Electronic Book Chapter
• Language: English
• Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Subjects: Medicine; adverse events; lower-urinary-tract dysfunction; therapeutic efficacy; urinary incontinence; voiding dysfunction; botulinum toxin A; onabotulinum toxin A; bladder pain syndrome/interstitial cystitis; long-term treatment; bladder pain syndrome; interstitial cystitis; Sapylin; liposome; bladder oversensitivity; detrusor overactivity; interstitial cystitis/bladder pain syndrome; botulinum toxin A injection; urine biomarkers; bladder inflammation; botulinum toxin; urethral; detrusor underactivity; urethral sphincter dysfunction; dysfunctional voiding; poor relaxation of the external sphincter; botulinum toxins; type A; urinary bladder; overactive; aged; postoperative complications; spinal cord injury; neurogenic bladder; onabotulinumtoxinA; botox; platelet-rich plasma; intravesical injection; incontinence; Parkinson's disease; stroke; dyssynergia; overactive bladder; men; lower urinary tract symptoms; n/a
• Online Access: DOAB: download the publication; DOAB: description of the publication

Evidence has shown that botulinum toxin A has advantages in lower urinary tract dysfunctions (LUTDs), especially in interstitial cystitis, urethral sphincter dysfunction, and inflammatory bladder disorders which currently cannot be adequately treated with oral pharmacological medications. This Special Issue has collected original or review articles that focus on the novel applications of botulinum toxin A in LUTDs. The research has been updated and contains novel therapeutic applications of botulinum toxin for bladder or urethral dysfunctions. This Special Issue of Toxins provides current knowledge surrounding the status of botulinum toxin in functional urology and LUTDs.